Chemcon Q1 FY27: standalone PAT up 72% YoY as margins expand sharply on 24% revenue growth

Chemcon Speciality Chemicals reported standalone revenue of ₹66.49 Cr for Q1 FY27 (quarter ended June 30, 2026), up 24.2% year-on-year from ₹53.52 Cr, with net profit up 71.6% YoY to ₹10.96 Cr from ₹6.39 Cr. Basic EPS rose to ₹2.99 from ₹1.74 a year ago. Sequentially, revenue was down 11.9% from ₹75.42 Cr in Q4 FY26 (audited), even though PAT rose 72.1% QoQ from ₹6.37 Cr — the sequential profit jump is a margin recovery off a weak Q4 base, not a sign of stronger sequential volumes, and should not be read as the headline story. The margin move is the real story: operating margin (EBITDA/revenue) expanded to 23.2% from 14.5% a year ago and 11.8% in Q4 FY26, while net margin (PAT/total income) rose to 15.6% from 11.2% YoY and 8.0% in Q4 FY26. Two things drove it — combined material-related costs (cost of materials, traded-goods purchases, net of inventory movement) fell to 55.5% of revenue from 58.8% YoY, and other expenses fell to 12.7% of revenue from 17.4% YoY, pointing to genuine operating leverage on the cost side. Part of the material-cost relief, however, rides on an unusually large inventory build this quarter (-₹7.61 Cr in the 'changes in inventories' line versus +₹1.95 Cr a year ago) — a working-capital swing that reduced reported cost of goods sold and may not repeat, so the quality of this quarter's margin print is not fully clean. Finance costs rose to ₹0.85 Cr from ₹0.34 Cr and depreciation to ₹3.75 Cr from ₹2.72 Cr, consistent with ongoing capacity-related capex; effective tax rate was 24.7%, broadly flat versus 24.2% a year ago. No consensus/street estimates for this quarter could be located for this small-cap name, so vs-street stands unknown rather than assumed; similarly, the company has no formal prior guidance on record in our data or via web search, so vs-guidance is unknown rather than inferred. There is no management press release or concall commentary available yet to cross-check management's own framing of the quarter. This is a standalone-only filing — the company confirms it has no subsidiary, associate or joint venture as of June 30, 2026 — so there is no consolidated number to reconcile against. The quarter's other board actions (AGM notice for September 17, 2026, directors' report for FY26, auditor reappointment, and the trading-window closure ahead of results) are administrative and unrelated to the operating numbers. Going into Q2 FY27, the key test is whether the OPM print holds above 20% once the inventory swing normalizes, or reverts toward the 11-15% band the company ran at through FY26 — that will tell whether this quarter's cost efficiency is structural or a one-quarter working-capital effect.